894 related articles for article (PubMed ID: 29914894)
1. LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.
Bian Z; Zhang J; Li M; Feng Y; Wang X; Zhang J; Yao S; Jin G; Du J; Han W; Yin Y; Huang S; Fei B; Zou J; Huang Z
Clin Cancer Res; 2018 Oct; 24(19):4808-4819. PubMed ID: 29914894
[No Abstract] [Full Text] [Related]
2. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.
Zhao X; Cheng Z; Wang J
Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA FEZF1-AS1 in human cancers.
Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X
Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.
Chen N; Guo D; Xu Q; Yang M; Wang D; Peng M; Ding Y; Wang S; Zhou J
Oncotarget; 2016 Mar; 7(10):11271-83. PubMed ID: 26848625
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
8. Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.
Zhu LF; Song LD; Xu Q; Zhan JF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5122-5132. PubMed ID: 31298365
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
12. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
14. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis.
Li QY; Chen L; Hu N; Zhao H
Biomed Pharmacother; 2018 Jul; 103():1727-1732. PubMed ID: 29864963
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G
Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796
[TBL] [Abstract][Full Text] [Related]
17. Upregulated long noncoding RNAs LINC02163 and FEZF1-AS1 exert oncogenic roles in colorectal cancer.
Tian Y; Zhou J; Zou Y; Luo B; Liu Q; Cao X
Anticancer Drugs; 2021 Jan; 32(1):66-73. PubMed ID: 32932277
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p/PRRX1 pathway.
Zhang T; Yu S; Zhao S
Adv Clin Exp Med; 2021 Aug; 30(8):839-848. PubMed ID: 34286520
[TBL] [Abstract][Full Text] [Related]
19. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling.
Liu Z; Wang N; Wang F; Zhang S; Ding J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738
[TBL] [Abstract][Full Text] [Related]
20. Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer.
Mo S; Zhang L; Dai W; Han L; Wang R; Xiang W; Wang Z; Li Q; Yu J; Yuan J; Cai S; Cai G
Cell Death Dis; 2020 Feb; 11(2):155. PubMed ID: 32111819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
